Business Context and Reporting Period
Company: Healthcare Realty Trust Incorporated (HR)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: A self-managed REIT owning, leasing, and managing income-producing real estate primarily associated with outpatient healthcare services. The portfolio consists of 589 consolidated properties and 63 unconsolidated joint ventures across 33 states, with a gross investment of approximately $11.8 billion as of year-end.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenues | $1.27 billion | $1.34 billion |
| Net Loss Attributable to Common Stockholders | $(654.5) million | $(278.3) million |
| Funds From Operations (FFO) | $193.3 million | $547.1 million |
| Normalized FFO | $576.8 million | $601.5 million |
| Funds Available for Distribution (FAD) | $419.1 million | $440.5 million |
| Cash Flow from Operating Activities | $501.6 million | $499.8 million |
| Total Debt Outstanding (Principal) | $4.89 billion | $5.00 billion |
| Weighted Average Interest Rate (Effective) | 4.72% | N/A |
| Portfolio Occupancy | 88.0% | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Rental income decreased by $76.4 million (5.8%) primarily due to dispositions in 2023 and 2024 ($96.3 million impact) and revenue reversals related to tenant bankruptcies (Steward Health and Prospect Medical).
- Significant Impairments: The Company recorded a full goodwill impairment of $250.5 million and real estate asset impairments of $249.9 million associated with completed or planned dispositions. These non-cash charges drove the net loss.
- Dispositions: The Company disposed of 67 properties in 2024 for total sales prices of $1.5 billion, generating net cash proceeds of $1.2 billion. No property acquisitions were completed in 2024.
- Joint Ventures: Investments in unconsolidated joint ventures increased by $172.7 million due to contributions of medical outpatient properties.
- Share Repurchases: The Company repurchased 30.8 million shares of common stock for $509.8 million during the year.
Guidance, Outlook, and Risks
Management Commentary:
- Liquidity: Management believes liquidity is adequate, supported by cash on hand, operating cash flows, and a $1.5 billion unsecured credit facility with no outstanding borrowings as of year-end.
- Dividends: The Company declared and paid $1.24 per share in dividends for 2024. A quarterly dividend of $0.31 per share was declared in February 2025.
- Leadership Transition: The former CEO departed in late 2024; Constance B. Moore serves as Interim CEO while a search for a permanent replacement is underway.
Key Risks and Contingencies:
- Tenant Bankruptcies: Steward Health (filed Chapter 11 in May 2024) and Prospect Medical (filed Chapter 11 in January 2025) have impacted revenue. Steward rejected leases representing $13.0 million in annual revenue; the Company is pursuing claims for unpaid rent.
- Debt Maturities: Approximately $1.5 billion of debt matures in 2025 and 2026. The Company has $1.5 billion available on its credit facility to manage refinancing needs.
- Regulatory Environment: Ongoing changes in Medicare reimbursement rates (site-neutral payment policies) and potential legislative changes regarding REIT ownership of healthcare facilities pose risks to tenant profitability and lease renewals.
- Interest Rate Sensitivity: While the Company has hedged a portion of its variable rate debt with interest rate swaps ($1.1 billion notional), rising rates could increase borrowing costs for new debt.
Investor Verification Checklist
- Goodwill Impairment: Verify the assumptions used in the fair value assessment that led to the $250.5 million goodwill write-down.
- Steward Health Recovery: Monitor the status of bankruptcy claims and the re-leasing of the 349,000 square feet of space rejected by Steward Health.
- Debt Refinancing: Assess the Company's ability to refinance the $1.5 billion in debt maturing in 2025-2026 given current interest rate environments.
- CEO Succession: Track the timeline and outcome of the search for a permanent Chief Executive Officer.
- Disposition Proceeds Reinvestment: Evaluate the Company's strategy for redeploying the $1.2 billion in net disposition proceeds, given the lack of acquisitions in 2024.